{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:00:55Z","timestamp":1648875655252},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00115-010-3077-6","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T17:13:21Z","timestamp":1279041201000},"page":"459-461","source":"Crossref","is-referenced-by-count":5,"title":["Fols\u00e4uresubstitution bei Frauen mit Epilepsie"],"prefix":"10.1007","volume":"82","author":[{"given":"J.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u00f6s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"R\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Stoffel-Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"3077_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0020-7292(97)83388-7","volume":"56","author":"ACOG","year":"1997","unstructured":"ACOG Educational Bulletin (1997) Seizure disorders in pregnancy. Int J Gynaecol Obstet 56:279\u2013286","journal-title":"Int J Gynaecol Obstet"},{"key":"3077_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L","volume":"62","author":"Czeizel","year":"1996","unstructured":"Czeizel AE (1996) Reduction of urinary tract and cardiovascular defects by periconceptional vitamin supplementation. Am J Med Genet A 62:19\u2013183","journal-title":"Am J Med Genet A"},{"key":"3077_CR3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","volume":"327","author":"Czeizel","year":"1992","unstructured":"Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832\u20131835","journal-title":"N Engl J Med"},{"key":"3077_CR4","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.274.21.1698","volume":"274","author":"Daly","year":"1995","unstructured":"Daly LE, Kirke PN, Molloy A et al (1995) Folate levels and neural tube defects. Implications for prevention. JAMA 274:1698\u20131702","journal-title":"JAMA"},{"key":"3077_CR5","unstructured":"Greiling H, Gressner AM (1995) Lehrbuch der klinischen Chemie und Pathobiochemie. Schattauer, Stuttgart New York"},{"key":"3077_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1059-1311(97)80007-6","volume":"6","author":"Isoj\u00e4rvi","year":"1997","unstructured":"Isoj\u00e4rvi JIT, Pakarinen AJ, Myllyl\u00e4 VV (1997) Basic haematological parameteres, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy. Seizure 6:207\u2013211","journal-title":"Seizure"},{"key":"3077_CR7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1471-0528.2007.01552.x","volume":"115","author":"Kjaer","year":"2008","unstructured":"Kjaer D, Horvath-Puho E, Christensen J et al (2008) Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG 115:98\u2013103","journal-title":"BJOG"},{"key":"3077_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00001648-199505000-00004","volume":"6","author":"Li","year":"1995","unstructured":"Li DK, Daling JR, Mueller BA et al (1995) Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:212\u2013218","journal-title":"Epidemiology"},{"key":"3077_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","volume":"338","author":"MRC","year":"1991","unstructured":"MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131\u2013137","journal-title":"Lancet"},{"key":"3077_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0920-1211(92)90011-H","volume":"13","author":"Sander","year":"1992","unstructured":"Sander JWAS, Patsalos PN (1992) An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res 13:89\u201392","journal-title":"Epilepsy Res"},{"key":"3077_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(95)92778-6","volume":"346","author":"Shaw","year":"1995","unstructured":"Shaw GM, Lammer EJ, Wassermann CR et al (1995) Risk of orofacial clefts in women using multivitamins containing folic acid periconceptionally. Lancet 346:393\u2013396","journal-title":"Lancet"},{"key":"3077_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/tera.1420490210","volume":"49","author":"Shaw","year":"1994","unstructured":"Shaw GM, Wassermann CR, O\u2019Malley CD (1994) Periconceptional vitamin use and reduced risk for conotruncal and limb defects in California. Teratol 49:372","journal-title":"Teratol"},{"key":"3077_CR13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1701-2163(16)30248-1","volume":"25","author":"Wilson","year":"2003","unstructured":"Wilson RD, Davies G, Desiltes V et al (2003) The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 25:959\u2013973","journal-title":"J Obstet Gynaecol Can"},{"key":"3077_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.61.6_suppl_2.S23","volume":"61","author":"Yerby","year":"2003","unstructured":"Yerby MS (2003) Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurol 61(Suppl\u00a02):23\u201326","journal-title":"Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-3077-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-3077-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-3077-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:08:47Z","timestamp":1558588127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-3077-6"}},"subtitle":["Evaluation des Substitutionseffektes durch intraerythrozyt\u00e4re Fols\u00e4urebestimmung"],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-3077-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}